The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The Human Gut Microbiome – A Potential Controller of Wellness and Disease
Open accessAbstract
Trillions of microorganisms co-evolve and dwell symbiotically with the human host, primarily inhabiting our gastrointestinal tract. These gastrointestinal microbes play remarkable roles in human wellness and disease. In this review, the interactions between gut microbiota and the host have been focused on, to provide an overview of the role of gut microbiota in host physiological functions such as metabolism, immunity and protection against pathogens. We elaborate on how the gut microbial imbalance (dysbiosis) may lead to pathogenesis and progression of diseases such as Clostridium difficile infection, inflammatory bowel disease, autism spectrum disorder and obesity. Recent advances in novel therapies derived from microbiome studies to target associated diseases have been reviewed. Despite the ongoing debate on whether gut microbiome plays a role in the above-mentioned diseases, we have in this review gathered evidence showing a clear link between gut microbial dysbiosis and most of these diseases. Underlying mechanisms to many of these microbiome imbalances thus leading to disease, remain to be elucidated. Future microbiome research using the human model need to be undertaken, along with application of standardized experimental protocols to reduce the huge variations in findings across currently available overlapping studies is highly recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Christensen, D. L., Baio, J., Braun, K. V. N., Bilder, D., Charles, J., Constantino, J. N., Daniels, J., Durkin, M. S., Fitzgerald, R. T., Kurzius-Spencer, M., et al. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6503a1 · Cited by 1,964
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Revised Estimates for the Number of Human and Bacteria Cells in the Body
Sender, R., Fuchs, S., & Milo, R. (2016) · PLOS Biology · doi:10.1371/journal.pbio.1002533 · Cited by 5,425
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888 · cited 1×
“Similarly, Sivan et al. (2015) reported that Bifidobacterium could facilitate PD-L1 blockade efficacy via augmenting DCs function, enhancing CD8+ T-cell priming and accumulation at the tumor microenvironment level.”
BackgroundDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Cited by
Regulation of Intestinal Barrier Function by Microbial Metabolites
Ghosh, S., Whitley, C. S., Haribabu, B., & Jala, V. R. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.02.007 · Cited by 835
Human gut microbiota in health and disease: Unveiling the relationship
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999001 · Cited by 762
Massive expansion of human gut bacteriophage diversity
Camarillo-Guerrero, L. F., Almeida, A., Rangel-Pineros, G., Finn, R. D., & Lawley, T. D. (2021) · Cell · doi:10.1016/j.cell.2021.01.029 · Cited by 594
Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020395 · Cited by 551
Mucosal-associated invariant T cells and disease
Toubal, A., Nel, I., Lotersztajn, S., & Lehuen, A. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0191-y · Cited by 300
One health, fermented foods and gut microbiota
Bell, V., Ferrão, J., Pimentel, L., Pintado, M., & Fernandes, T. (2018) · Foods · doi:10.3390/foods7120195 · Cited by 188
Microglia regulation of central nervous system myelin health and regeneration
Kent, S. A., & Miron, V. E. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00907-4 · Cited by 183
Lee, H.-J., Lee, K.-E., Kim, J.-K., & Kim, D.-H. (2019) · Scientific Reports · doi:10.1038/s41598-019-48342-7 · Cited by 164
Myelin as a regulator of development of the microbiota-gut-brain axis
Keogh, C. E., Kim, D. H. J., Pusceddu, M. M., Knotts, T. A., Rabasa, G., Sladek, J. A., Hsieh, M. T., Honeycutt, M., Brust-Mascher, I., Barboza, M., et al. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.001 · Cited by 137
d’Afflitto, M., Upadhyaya, A., Green, A., & Peiris, M. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001676 · Cited by 142
Postbiotics: metabolites and mechanisms involved in microbiota-host interactions
Peluzio, M. D. C. G., Martinez, J. A., & Milagro, F. I. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.004 · Cited by 139
Probiotics: If It Does Not Help It Does Not Do Any Harm. Really?
Lerner, A., Shoenfeld, Y., & Matthias, T. (2019) · Microorganisms · doi:10.3390/microorganisms7040104 · Cited by 117
Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
Zheng, S.-Y., Li, H.-X., Xu, R.-C., Miao, W.-T., Dai, M.-Y., Ding, S.-T., & Liu, H.-D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101347 · Cited by 101
Wise, J. L., & Cummings, B. P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1093420 · Cited by 94
The Emerging Role of Polyphenols in the Management of Type 2 Diabetes
Wang, Y., Alkhalidy, H., & Liu, D. (2021) · Molecules · doi:10.3390/molecules26030703 · Cited by 88
MiMeNet: Exploring microbiome-metabolome relationships using neural networks
Reiman, D., Layden, B. T., & Dai, Y. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009021 · Cited by 80
Ballway, J. W., & Song, B.-J. (2021) · Antioxidants · doi:10.3390/antiox10030384 · Cited by 72
Son, Y. S., Ki, S. J., Thanavel, R., Kim, J., Lee, M., Kim, J., Jung, C., Han, T., Cho, H., Ryu, C., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000063r · Cited by 45
The oral microbiome, nitric oxide and exercise performance
Bryan, N. S., Burleigh, M. C., & Easton, C. (2022) · Nitric Oxide · doi:10.1016/j.niox.2022.05.004 · Cited by 46
Tsigalou, C., Paraschaki, A., Karvelas, A., Kantartzi, K., Gagali, K., Tsairidis, D., & Bezirtzoglou, E. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100081 · Cited by 40
Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity
Baiden-Amissah, R. E. M., & Tuyaerts, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143586 · Cited by 30
Association between Helicobacter py lori infection and Guillain‐Barré Syndrome: A meta‐analysis
Dardiotis, E., Sokratous, M., Tsouris, Z., Siokas, V., Mentis, A. A., Aloizou, A., Michalopoulou, A., Bogdanos, D. P., Xiromerisiou, G., Deretzi, G., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13218 · Cited by 31
Gravity, Microgravity and Artificial Gravity: Physiological Effects, Implementation and Applications
Goswami, N., Blaber, A. P., Valenti, G., Hinghofer-Szalkay, H., Evans, J., Bailey, D. M., Vernikos, J., Choukér, A., Green, D. A., White, O., et al. (2026) · Physiological Reviews · doi:10.1152/physrev.00055.2024 · Cited by 25
Wallen-Russell, C., Pearlman, N., Wallen-Russell, S., Cretoiu, D., Thompson, D. C., & Voinea, S. C. (2023) · Microorganisms · doi:10.3390/microorganisms11112784 · Cited by 14
Clostridioides difficile and neurological disorders: new perspectives
Biazzo, M., Allegra, M., & Deidda, G. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946601 · Cited by 11
Elucidating the Role of Gut-Brain-Axis in Neuropsychiatric and Neurological Disorders
Lalnundika, B., Hassan, S., Prathiviraj, R., Kumar, H. K., Qadri, S., Kiran, G. S., Bramhachari, P. V., & Selvin, J. (2023) · Human Microbiome in Health, Disease, and Therapy · doi:10.1007/978-981-99-5114-7_2 · Cited by 2
Metadata
- Authors
- Kho, Z. Y., & Lal, S. K.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-08-14
- Volume
- 9
- Pages
- 1835-1835
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2885492105
- Cited by
- 1,104
- References
- 55
- FWCI
- 32.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
